About Inserm Transfert
Inserm Transfert is a company based in Paris (France) founded in 2000. Inserm Transfert offers products and services including Technology Transfer and Collaborative Funding.
- Headquarter Paris, France
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inserm Transfert
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$216.27 K (USD), Grant
Sep 01, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inserm Transfert
Inserm Transfert offers a comprehensive portfolio of products and services, including Technology Transfer and Collaborative Funding.
Technology transfer is conducted to protect and commercialize research outcomes in life sciences, linking fundamental research to clinical applications.
Collaborative funding is provided for projects that involve partnerships with industries and investors to support innovation and societal impact.
Funding Insights of Inserm Transfert
Investors in Inserm Transfert
Inserm Transfert has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Inserm Transfert
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inserm Transfert
Investment portfolio details for Inserm Transfert
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Inserm Transfert
Detailed financials for Inserm Transfert
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inserm Transfert Comparisons
Peer comparison for Inserm Transfert
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inserm Transfert
Detailed competitors of Inserm Transfert
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inserm Transfert
Complete news archive for Inserm Transfert
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inserm Transfert
Inserm Transfert was founded in 2000 and raised its 1st funding round 11 years after it was founded.
Inserm Transfert is headquartered in Paris, France.
Inserm Transfert was founded in 2000 and is based in Paris, France. Operations are centered on venture capital activities within the healthcare sector. Early-stage companies operating across France are targeted for investments. Assistance is extended to health innovation projects, including those in biotechnology and medical technologies. The firms domain, inserm-transfert.fr, facilitates these investment and transfer initiatives in the French ecosystem.
Inserm Transfert offers Technology Transfer and Collaborative Funding.
Inserm Transfert has 1 investor. Key investors include European Union.